October 11, 2024
TOPLINE: A study has found that less than half of US veterans on chronic immunosuppressive medications, and a much lower percentage of those younger than 50 […]
October 9, 2024
TOPLINE: Long-term antibiotic usage is associated with an increased risk for rheumatoid arthritis (RA). METHODOLOGY: Researchers conducted a population-based retrospective cohort study using data from the […]
October 8, 2024
TOPLINE: Coordinated care in a combined rheumatology and ophthalmology clinic for managing pediatric anterior uveitis resulted in better outcomes, quicker initiation of biologic disease-modifying antirheumatic drugs […]
October 7, 2024
A 1-year course of methotrexate (MTX) in clinically suspected arthralgia may prevent the development of rheumatoid arthritis (RA) in at-risk individuals who test negative for anti-citrullinated […]
October 7, 2024
TOPLINE: A higher rate of weight loss within 1 year of initiating orlistat is associated with lower risks for incident gout and recurrent gout flares in […]
October 7, 2024
TOPLINE: Older adults with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis face a higher risk for end-stage renal disease or mortality and severe infections. However, frailty, more than […]
October 4, 2024
TOPLINE: Patients with inflammatory rheumatic diseases who are systematically screened for common chronic and preventable diseases are more likely to receive preventive medications and less likely […]
October 1, 2024
The US Food and Drug Administration has approved ustekinumab-aauz (Otulfi), a biosimilar that references Johnson & Johnson’s ustekinumab (Stelara). This is the fourth ustekinumab biosimilar approved […]
September 30, 2024
A noninvasive eye test could help people with Sjögren disease — a disorder that can go undiagnosed for years — get relief sooner, suggested a pilot […]